Literature DB >> 1649858

Cardioprotective potential of angiotensin converting enzyme inhibitors.

H Gavras, I Gavras.   

Abstract

Mesh:

Substances:

Year:  1991        PMID: 1649858     DOI: 10.1097/00004872-199105000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  8 in total

1.  The renin-angiotensin system and the heart: a historical review.

Authors:  S J Cleland; J L Reid
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 2.  Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view.

Authors:  M H Alderman
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

3.  Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Authors:  Y H Liu; X P Yang; V G Sharov; O Nass; H N Sabbah; E Peterson; O A Carretero
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Treatment of hypertension with valsartan combined with spironolactone.

Authors:  A Leone; F Bertanelli; L Mori
Journal:  Int Urol Nephrol       Date:  2000       Impact factor: 2.370

5.  Effects of ACE inhibitors on oxidation of human low density lipoprotein.

Authors:  E G Godfrey; J Stewart; H J Dargie; J L Reid; M Dominiczak; C A Hamilton; J McMurray
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

Review 6.  Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.

Authors:  B Pitt; P Chang; P B Timmermans
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

7.  Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.

Authors:  Thomas J Bahk; Melvin D Daniels; Juan S Leon; Kegiang Wang; David M Engman
Journal:  Int J Cardiol       Date:  2007-06-22       Impact factor: 4.164

Review 8.  Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure.

Authors:  J E Frampton; D H Peters
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.